Skip to main content
Fig. 6 | Orphanet Journal of Rare Diseases

Fig. 6

From: Haploidentical haematopoietic stem cell transplantation for malignant infantile osteopetrosis and intermediate osteopetrosis: a retrospective analysis of a single centre

Fig. 6

The 5-year overall survival (OS) rates of all patients with osteopetrosis who underwent HSCT was 76.7% (A). The 5-year overall survival (OS) rate was 73.9% in patients who underwent haplo-HSCT (B). A comparison of patients with MIOP and IOP did not reveal a statistically significant difference (69.6% vs. 100.0%, P = 0.2444) (C). ALL: all patients

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172